Medical Devices
Adiana
BARRx
Crux Biomedical
Diomed Holdings
EKOS
Guava Technologies
Gynesonics
Light Sciences Oncology
Novasys Medical
Optiscan Biomedical
Power Medical Interventions
TransMedics
Xillix Technologies
 
Xillix Technologies
100- 13775 Commerce Parkway
Richmond, British Columbia, Canada V6V 2V4
604 278 5000
 
Xillix Technologies Corp. is a Canadian medical device company and the world leader in fluorescence endoscopy for improved cancer detection. Xillix’s latest device, Onco-LIFE™, incorporates fluorescence and white-light endoscopy in a single device that has been developed for the detection and localization of lung and gastrointestinal (GI) cancers. An international multicenter lung cancer clinical trial of Onco-LIFE demonstrated a 325% per- lesion improvement in the detection of early lung cancer (moderate-severe dysplasia and carcinoma in situ) and a 250% per-patient improvement compared to white-light alone. Onco- LIFE is approved for sale in the United States for the lung application and in Europe and Canada for both lung and GI applications. Onco- LIFE is compact, user-friendly and is compatible with a wide range of endoscopes and endoscopic accessories to help maximize global market acceptance.

The Company is listed on the Toronto Stock Exchange under the trading symbol “XLX”.